PCRX
Pacira BioSciences, Inc. NASDAQ Listed Feb 3, 2011$23.66
Mkt Cap $930.7M
52w Low $18.80
55.0% of range
52w High $27.64
50d MA $23.41
200d MA $23.67
P/E (TTM)
152.8x
EV/EBITDA
12.2x
P/B
1.6x
Debt/Equity
0.7x
ROE
1.0%
P/FCF
8.4x
RSI (14)
—
ATR (14)
—
Beta
0.20
50d MA
$23.41
200d MA
$23.67
Avg Volume
719.0K
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
5401 West Kennedy Boulevard · Tampa, FL 33609 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.61 | 0.60 | -1.6% | 25.49 | +5.5% | -4.1% | -3.1% | -2.7% | -7.1% | -7.3% | — |
| Feb 26, 2026 | AMC | 0.85 | 0.57 | -32.9% | 22.59 | -6.4% | -3.0% | -5.8% | -2.2% | +1.2% | +1.2% | — |
| Nov 6, 2025 | AMC | 0.65 | 0.70 | +7.7% | 21.10 | -3.7% | +4.5% | +9.3% | +14.3% | +13.1% | +11.9% | — |
| Aug 5, 2025 | AMC | 0.72 | 0.74 | +2.8% | 22.54 | -1.3% | -0.6% | +5.5% | +11.7% | +11.8% | +10.1% | — |
| May 8, 2025 | AMC | 0.57 | 0.62 | +8.8% | 24.91 | -7.7% | +0.8% | +0.7% | -6.1% | -1.8% | +2.8% | — |
| Feb 27, 2025 | AMC | 0.78 | 0.91 | +16.7% | 25.38 | +2.4% | -5.2% | -9.5% | -7.3% | -7.4% | -6.0% | — |
| Nov 6, 2024 | AMC | 0.72 | 0.79 | +9.7% | 17.67 | -0.5% | +0.2% | -2.4% | -1.0% | -4.9% | -6.9% | — |
| Jul 30, 2024 | AMC | 0.73 | 0.89 | +21.9% | 19.54 | +13.6% | +5.7% | +6.2% | +8.8% | +3.3% | +10.6% | — |
| May 7, 2024 | AMC | 0.64 | 0.62 | -3.1% | 26.51 | +9.0% | +11.8% | +12.6% | +11.0% | +14.6% | +16.3% | — |
| Feb 29, 2024 | AMC | 0.89 | 0.89 | +0.0% | 29.72 | -0.1% | -2.9% | -1.7% | -0.9% | +1.3% | +3.1% | — |
| Nov 2, 2023 | AMC | 0.84 | 0.72 | -14.3% | 29.19 | +2.0% | +6.3% | +5.3% | +3.7% | +2.5% | -2.6% | — |
| Aug 2, 2023 | AMC | 0.81 | 0.78 | -3.7% | 36.71 | +2.1% | +5.6% | +7.5% | +3.9% | +4.0% | +3.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $25.49 | $26.90 | +5.5% | -4.1% | -3.1% | -2.7% | -7.1% | -7.3% |
| May 1 | Needham | Maintains | Buy → Buy | — | $25.49 | $26.90 | +5.5% | -4.1% | -3.1% | -2.7% | -7.1% | -7.3% |
| Mar 26 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.49 | $23.27 | -0.9% | -0.8% | -2.6% | -0.9% | -3.8% | -3.0% |
| Jan 9 | Needham | Maintains | Buy → Buy | — | $26.02 | $24.64 | -5.3% | -9.6% | -11.9% | -17.0% | -14.5% | -20.6% |
| Jan 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.02 | $24.64 | -5.3% | -9.6% | -11.9% | -17.0% | -14.5% | -20.6% |
| Nov 7 | Truist | Maintains | Buy → Buy | — | $21.10 | $20.32 | -3.7% | +4.5% | +9.3% | +14.3% | +13.1% | +11.9% |
| May 9 | Needham | Maintains | Buy → Buy | — | $24.91 | $23.00 | -7.7% | +0.8% | +0.7% | -6.1% | -1.8% | +2.8% |
| Apr 8 | Needham | Maintains | Buy → Buy | — | $22.91 | $27.60 | +20.5% | +14.7% | +12.8% | +3.4% | +7.2% | +9.0% |
| Apr 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $22.91 | $27.60 | +20.5% | +14.7% | +12.8% | +3.4% | +7.2% | +9.0% |
| Feb 28 | Needham | Maintains | Buy → Buy | — | $25.38 | $26.00 | +2.4% | -5.2% | -9.5% | -7.3% | -7.4% | -6.0% |
| Feb 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.38 | $26.00 | +2.4% | -5.2% | -9.5% | -7.3% | -7.4% | -6.0% |
| Feb 28 | Barclays | Maintains | Overweight → Overweight | — | $25.38 | $26.00 | +2.4% | -5.2% | -9.5% | -7.3% | -7.4% | -6.0% |
| Jan 30 | Truist | Upgrade | Sell → Hold | — | $26.03 | $27.00 | +3.7% | +0.8% | +1.2% | -1.1% | +2.2% | +4.1% |
| Jan 14 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $21.13 | $21.12 | -0.0% | -2.7% | +3.5% | +4.4% | +5.8% | +8.1% |
| Jan 13 | Needham | Maintains | Buy → Buy | — | $20.64 | $21.01 | +1.8% | +2.4% | -0.4% | +6.0% | +6.9% | +8.3% |
| Dec 17 | Needham | Maintains | Buy → Buy | — | $19.87 | $19.72 | -0.8% | -0.2% | -3.4% | -1.5% | -4.5% | -3.4% |
| Dec 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.68 | $16.71 | +0.2% | +14.4% | +11.9% | +15.5% | +14.4% | +18.5% |
| Nov 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $17.50 | $17.13 | -2.1% | -4.0% | -6.0% | -6.5% | -5.1% | -4.9% |
| Nov 8 | Needham | Maintains | Buy → Buy | — | $17.70 | $17.59 | -0.6% | -2.6% | -1.1% | -5.1% | -7.1% | -7.5% |
| Nov 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $17.67 | $17.58 | -0.5% | +0.2% | -2.4% | -1.0% | -4.9% | -6.9% |
| Oct 4 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $15.89 | $16.05 | +1.0% | +4.0% | +0.6% | -1.4% | -2.0% | -2.4% |
| Sep 24 | Jefferies | Maintains | Buy → Buy | — | $14.28 | $14.45 | +1.2% | -0.1% | -2.6% | +0.4% | +1.8% | +5.4% |
| Aug 13 | Truist | Downgrade | Buy → Sell | — | $12.29 | $11.55 | -6.0% | +0.9% | +1.5% | +8.6% | +5.3% | +13.8% |
| Aug 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.70 | $12.06 | +3.1% | +5.0% | +6.0% | +6.6% | +14.1% | +10.6% |
| Aug 12 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $11.70 | $12.06 | +3.1% | +5.0% | +6.0% | +6.6% | +14.1% | +10.6% |
| Aug 12 | Needham | Maintains | Buy → Buy | — | $11.70 | $12.06 | +3.1% | +5.0% | +6.0% | +6.6% | +14.1% | +10.6% |
| Aug 12 | JP Morgan | Downgrade | Overweight → Underweight | — | $11.70 | $12.06 | +3.1% | +5.0% | +6.0% | +6.6% | +14.1% | +10.6% |
| Aug 1 | Jefferies | Maintains | Buy → Buy | — | $20.65 | $20.85 | +1.0% | +0.5% | +3.0% | -2.3% | +4.6% | +8.1% |
| Jul 31 | Needham | Maintains | Buy → Buy | — | $19.54 | $22.19 | +13.6% | +5.7% | +6.2% | +8.8% | +3.3% | +10.6% |
| Jul 31 | RBC Capital | Maintains | Outperform → Outperform | — | $19.54 | $22.19 | +13.6% | +5.7% | +6.2% | +8.8% | +3.3% | +10.6% |
| Jul 31 | Raymond James | Maintains | Outperform → Outperform | — | $19.54 | $22.19 | +13.6% | +5.7% | +6.2% | +8.8% | +3.3% | +10.6% |
| Jul 25 | Truist | Maintains | Buy → Buy | — | $20.26 | $20.23 | -0.1% | -1.4% | -1.1% | +0.5% | -3.6% | +1.9% |
| Jul 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $22.74 | $21.71 | -4.5% | -4.7% | -7.4% | -9.4% | -7.8% | -10.6% |
| Jul 3 | Barclays | Downgrade | Overweight → Equal Weight | — | $22.74 | $21.71 | -4.5% | -4.7% | -7.4% | -9.4% | -7.8% | -10.6% |
| Jul 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $28.46 | $28.25 | -0.7% | -20.1% | -23.9% | -26.0% | -27.6% | -26.4% |
| Jul 2 | Needham | Maintains | Buy → Buy | — | $28.46 | $28.25 | -0.7% | -20.1% | -23.9% | -26.0% | -27.6% | -26.4% |
| May 8 | Barclays | Maintains | Overweight → Overweight | — | $26.51 | $28.90 | +9.0% | +11.8% | +12.6% | +11.0% | +14.6% | +16.3% |
| May 8 | Needham | Maintains | Buy → Buy | — | $26.51 | $28.90 | +9.0% | +11.8% | +12.6% | +11.0% | +14.6% | +16.3% |
| May 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.51 | $28.90 | +9.0% | +11.8% | +12.6% | +11.0% | +14.6% | +16.3% |
| Apr 9 | Needham | Maintains | Buy → Buy | — | $28.48 | $28.60 | +0.4% | +0.1% | -2.3% | -3.9% | -5.8% | -6.8% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $28.86 | $28.40 | -1.6% | +1.2% | +2.0% | +4.3% | +6.2% | +8.8% |
| Mar 1 | Needham | Maintains | Buy → Buy | — | $29.72 | $29.69 | -0.1% | -2.9% | -1.7% | -0.9% | +1.3% | +3.1% |
| Mar 1 | RBC Capital | Maintains | Outperform → Outperform | — | $29.72 | $29.69 | -0.1% | -2.9% | -1.7% | -0.9% | +1.3% | +3.1% |
| Feb 8 | Wedbush | Maintains | Outperform → Outperform | — | $28.49 | $28.55 | +0.2% | -2.8% | +1.0% | +5.4% | +2.5% | +2.6% |
| Nov 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $31.04 | $30.79 | -0.8% | -1.0% | -2.4% | -3.6% | -8.4% | -8.2% |
| Nov 3 | RBC Capital | Maintains | Outperform → Outperform | — | $29.19 | $29.76 | +2.0% | +6.3% | +5.3% | +3.7% | +2.5% | -2.6% |
| Nov 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $29.19 | $29.76 | +2.0% | +6.3% | +5.3% | +3.7% | +2.5% | -2.6% |
| Nov 3 | Needham | Maintains | Buy → Buy | — | $29.19 | $29.76 | +2.0% | +6.3% | +5.3% | +3.7% | +2.5% | -2.6% |
| Oct 23 | Barclays | Maintains | Overweight → Overweight | — | $28.51 | $28.29 | -0.8% | -1.8% | -1.0% | -4.5% | -4.3% | -3.3% |
| Oct 3 | RBC Capital | Maintains | Outperform → Outperform | — | $29.86 | $29.78 | -0.3% | -2.1% | -4.0% | -2.7% | -0.2% | +1.3% |
No insider trades available.
Data updated apr 26, 2026 6:58pm
· Source: massive.com